Department Of Otolaryngology Head And Neck Surgery 1
1. ARIA-EAACI care pathways for allergen immunotherapy in respiratory allergy
2. ARIA-EAACI care pathways for allergen immunotherapy in respiratory allergy
3. Concepts for the Development of Person-Centered, Digitally Enabled, Artificial Intelligence–Assisted ARIA Care Pathways (ARIA 2024)
4. Management of anaphylaxis due to COVID-19 vaccines in the elderly
5. Methodology for the Development of the Allergic Rhinitis and Its Impact on Asthma (ARIA)-EAACI 2024–2025 Guidelines: From Evidence-to-Decision Frameworks to Digitalised Shared Decision-Making Algorithms
6. Methodology for the Development of the Allergic Rhinitis and Its Impact on Asthma (ARIA)-EAACI 2024–2025 Guidelines: From Evidence-to-Decision Frameworks to Digitalised Shared Decision-Making Algorithms
7. Patient-centered digital biomarkers for allergic respiratory diseases and asthma: The ARIA-EAACI approach – ARIA-EAACI Task Force Report
8. Rhinitis associated with asthma is distinct from rhinitis alone: The ARIA-MeDALL hypothesis
9. Rhinitis associated with asthma is distinct from rhinitis alone: The ARIA-MeDALL hypothesis
10. Association between Helicobacterpylori, reflux and chronic rhinosinusitis: a systematic review
11. Association between Helicobacterpylori, reflux and chronic rhinosinusitis: a systematic review
12. Prevalence, incidence, and mortality rates of breast cancer in Kazakhstan: data from the Unified National Electronic Health System, 2014–2019
13. Endoscopic Features of Chronic Rhinosinusitis in Patients with Gastroesophageal Reflux Disease
14. The Diagnostic Accuracy of the Nasopharyngeal Reflux Endoscopic Score (NRES) for Identifying Laryngopharyngeal Reflux Disease in Chronic Rhinosinusitis
15. Allergen immunotherapy in MASK-air users in real-life: Results of a Bayesian mixed-effects model
16. Behavioural patterns in allergic rhinitis medication in Europe: A study using MASK-air® real-world data
17. Comparison of rhinitis treatments using MASK-air® data and considering the minimal important difference
18. Consistent trajectories of rhinitis control and treatment in 16,177 weeks: The MASK-air® longitudinal study
19. Laryngeal Stenosis Among Adults in Kazakhstan During 2019–2024: A Cross-Sectional Study
1